Dollar edges higher ahead of Fed minutes; sterling gains after CPI increase
SOUTH JORDAN, Utah - Merit Medical Systems , Inc. (NASDAQ:MMSI) reported better-than-expected first quarter results but saw its stock plunge 9.2% after lowering its full-year earnings guidance.
The healthcare technology manufacturer posted Q1 adjusted earnings per share of $0.86, surpassing analyst estimates of $0.75. Revenue rose 9.8% YoY to $355.4 million, also beating the consensus forecast of $352.52 million.
However, Merit Medical (TASE:BLWV) slashed its 2025 adjusted EPS guidance to $3.29-$3.42, down from its previous outlook of $3.58-$3.70 and below Wall Street’s expectation of $3.65. The company cited the projected impact of recently implemented trade policies as the reason for the reduced profit forecast.
"We delivered better-than-expected financial performance in the first quarter, with our constant currency revenue, organic, our constant currency total revenue and our non-GAAP EPS exceeding the high-end of our expectations," said Fred P. Lampropoulos, Merit’s Chairman and CEO.
Merit Medical maintained its full-year revenue guidance of $1.47-$1.49 billion, in line with analyst projections of $1.48 billion.
The company’s Q1 non-GAAP operating margin improved to 19.3% from 17.0% in the prior year period. Constant currency revenue growth was 10.9%, while organic constant currency growth came in at 6.0%.
Merit Medical ended the quarter with $395.5 million in cash and cash equivalents and total debt of $747.5 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.